Scientific programme
Scientific programme
This Congress will showcase a plethora of relevant topics in the exciting field of Transfusion Medicine, from recruitment of blood donors to the actual donation process, biology of blood cells, preparation of blood components, transfusion-transmitted infectious diseases, immunohaematology patient blood management, adverse transfusion events, cellular therapies, and much more. Follow the ISBT announcements for more information about Workshops and special sessions, such as the Young Investigator Breakfast Sessions.
The Local Day will be organised by the Canadian Society of Transfusion Medicine and will focus on 200 years of Transfusion Medicine. More information about the programme of the Local Day, the ISBT Academy Day and the parallel sessions will be made available on this page.
Simultaneous translation
On the Local Day (Saturday June 2) and Academy Day (Sunday June 3) simultaneous translation will be provided for French Canadians.
Click Here to Access the Congress Abstract Book
The congress abstract book is now available through the Wiley Online Library. You can freely access it online by clicking above, or access it via the congress app in due time.
Young Investigators Breakfast
On Tuesday June 5, 2018 a breakfast is organized to informally bring Young Investigators (under 40 years old) together with Transfusion Medicine experts. The breakfast is held in room 401 in the Metro Convention Centre, Toronto.
For more information click here.
Transfusion Practitioners
On Monday June 4, 2018 a networking breakfast is organized to bring Transfusion Practitioners together to meet new colleagues and share ideas. The breakfast is held in room 401 in the Metro Convention Centre, Toronto.
For more information click here.
Programme at a glance
Click here to view the scientific programme at a glance.
Abstract Presentation Guidelines
PROGRAMME PER DAY **
| 08.00 - 09.00 | Annual General Meeting of CSTM (Canadian Society of Transfusion Medicine) |
| 09.00 - 10.15 | Ortho and Buchanan Awards and Lectures |
| 10.15 - 10.30 | Break |
| 11.00 - 12.00 | History of transfusion medicine in Canada John Freedman |
| 12.00 - 13.00 | Lunch |
| 13.00 - 14.00 | The Canadian Blood Services turn 20: past, present and future Graham Sher |
| 14.00 - 14.30 | NAC/CCNMT update Jennifer Fesser and Heather Hume |
| 14.30 - 15.15 | From serology to genotyping and updates in testing Gwen Clarke |
| 15.15-15.30 | Break |
| 15.15 - 16.00 | Introduction to the new products Dana Devine |
| 16.00 -16.45 | Novel approaches to teaching transfusion medicine Yulia Lin |
| 16.45 - 17.30 | Cellular therapy comes of age Donna Wall |
| 17.30 | Adjourn |
| 09.00 - 10.30 | Donors & Donation |
| 09.00 - 09.30 | Apheresis donor eligibility criteria and selection in platelet, plasma and red cell collection C. Poole (South Africa) |
| 09.30 - 10.00 | Short and longer-term risk of donor apheresis M. Neyrinck (Belgium) |
| 10.00 - 10.30 | Establishing an apheresis service in a resource-limited setting B. Pheng (Cambodia) |
| 09.00 - 10.30 | Education and Training |
| 09.00 - 10.30 | Using simulation for training in clinical transfusion medicine A. Petrosoniak & K. Pavenski (Canada) |
| 10.30 - 11.00 | Coffee break |
| 11.00 - 12.30 | Organisation and Quality |
| 11.00 - 11.30 | Quality: what I know now that I wish I'd known then M. Smith (New Zealand) |
| 11.30 - 12.00 | Developing the quality team L. Bust (South Africa) |
| 12.00 - 12.30 | When things go badly: managing quality problems and complaints in transfusion medicine T. Vuk (Croatia) |
| 11.00 - 12.30 | Transfusion-transmitted infectious diseases |
| 11.00 - 11.15 | I TRY IT introduction B. Custer (USA) |
| 11.15 - 11.45 | I TRY IT research A.El Riyami (Oman) |
| 11.45 - 12.15 | I TRY IT research A. Sepeti, Fiji |
| 12.15 - 12.30 | Discussion |
| 12.00 - 13.30 | Satellite Symposia |
| 12.30 - 13.30 | Lunch Break |
| 13.30 - 15.00 | Immunohaematology |
| 13.30 - 14.00 | What's new in the Kell and Gerbich blood group systems P. Ligthart (Netherlands) |
| 14.00 - 14.30 | And now there are 49: update on the MNS blood group system C. Gassner (Switzerland) |
| 14.30 - 15.00 | Kidd blood group system: only 3 antigens but what about the variants? J. Hamilton (USA) |
| 13.30 - 15.00 | Clinical transfusion practice |
| 13.30 - 14.00 | Is it TACO, TRALI or something else? M. Looney (USA) |
| 14.00 - 14.30 | None too SMAll: the global challenge of severe malarial anaemia and its transfusion support C. Cserti-Gazdewich (Canada) |
| 14.30 - 15.00 | What is ECMO, and why do we use it in critical illness? E. Fan (Canada) |
| 15.00 - 15.30 | Break |
| 15.30 - 17.00 | Immunohaematology |
| 15.30 - 16.00 | After 70 years, serological RhD determination is still challenging: DNA to the rescue M. Pisacka (Czech Republic) |
| 16.00 - 16.30 | Getting comfortable with Rh blood group system terminologies and databases F. Werner (Germany) |
| 16.30 - 17.00 | Decision-making in complex obstetric cases: How to end up with a healthy baby in HDFN M. Delaney (USA) |
| 15.30 - 17.00 | Cellular therapies and haemovigilance |
| 15.30 - 16.00 | Microbial Safety of Cellular Therapeutics - Lessons from over ten years experience in microbial safety of platelet concentrates M. Störmer (Germany) |
| 16.00 - 16.30 | Adverse outcomes and substances of human origin: Cases from the NOTIFY Library E. Petrisli (Italy) |
| 16.30 - 17.00 | Safety and surveillance issues in stem cell marketing D. Sipp (Japan) |
| 17.45 - 21.00 | Opening Ceremony & Welcome Reception |
| 07.00 - 08.00 | Transfusion Practitioners |
| Networking Breakfast | |
| 08.30 - 10.00 | Immunobiology |
| 08.30 - 09.00 | Drug induced haemolytic anaemia D. Branch (Canada) |
| 09.00 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | Clinical |
| 08.30 - 09.00 | Challenges in PBM / Tools for PBM P. Meybohm (Germany) |
| 09.00 - 09.30 | Questioning the benefit of restrictive transfusion practice in older adults G. Simon (Australia) |
| 09.30 - 10.00 | The outcome of the Patient Blood Management Consensus Conference, Frankfurt April 2018 M.M. Mueller (Germany) |
| 08.30 - 10.00 | Donors and Donation |
| The effect of iron on fetal and neonatal brain development M. Georgieff (USA) | |
| The effect of blood donation of women on the birth weight of their offspring H. Ullum (Denmark) | |
| SELECTED ABSTRACTS | |
| 08.30 - 10.00 | Cellular Therapies |
| 08.30 - 09.00 | Cord blood expansion with novel small molecule G. Sauvageau (Canada) |
| 09.00 - 09.30 | The use of cord blood in metabolic disorders and hypoxic brain injuries J. Kurtzberg (USA) |
| 09.30 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | WP TTID |
| Overview of TTI WP mission, membership and activities C. Seed (Australia) | |
| Surveillance, risk assessment, and policy subgroup presentation S. O'Brien (Canada) | |
| Bacterial subgroup presentation C. McDonald (UK) | |
| Parasite subgroup presentation E. Bloch (USA) | |
| 08.30 - 10.00 | WP IT |
| Electronic identity control, replacement identification and multiple transfusions made easy in the OR/ER J. Georgsen (Denmark) | |
| Visibility and access to blood products via technology L. Briggs (USA) | |
| Practical consideration in implementing RFID for the blood supply S. Lam (Singapore) | |
| 10.00 - 10.30 | Coffee break |
| 10.30 - 12.00 | Plenary Session: Arthropod borne infections |
| 10.30 - 12.00 | Insect disease vectors and their impact on human health L. Harrington (USA) |
| 10.30 - 12.00 | Malarial resistance E. Leffler (UK) |
| 10.30 - 12.00 | The immune role of platelets in malaria B. McCorran (Australia) |
| 12.00 - 13.30 | Satellite Symposia |
| 12.00 - 14.00 | Lunch break |
| 14.00 - 15.30 | Donors & donation |
| 14.00 - 14.30 | Donor vasovagal reactions, how can we reduce them? J. Castren (Finland) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Blood products |
| 14.00 - 14.30 | Novel platelet products R. Cardigan (UK) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Blood safety |
| 14.00 - 14.30 | Bacterial contamination - CBS experience S. Ramirez Arcos (Canada) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Management & Organisation |
| 14.00 - 14.30 | Emergency preparedness for mass casualty events H. Doughty (UK) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Young investigators session |
| 14.00 - 15.30 | SELECTED ABSTRACTS |
| 15.30 - 16.00 | Coffee break |
| 16.00 - 17.30 | Blood products |
| 16.00 - 17.30 | Pathogen inactivation technologies D. Devine (Canada) |
| 16.30 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Blood safety |
| 16.00 - 16.30 | The development and use of a Donor history questionnaire in Pakistan I. Shabber (Pakistan) |
| 16.30 - 17.00 | Addressing Transfusion Transmitted malaria in Kenya V. Magutu (Kenya) |
| 17.00 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Clinical I |
| 16.00 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Immunobiology |
| 16.00 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Transfusion Practitioners |
| 16.00 - 16.30 | Disaster Planning: the role of the transfusion practitioner C. Akers (Australia) |
| 16.30 - 17.00 | The Transfusion Practitioner role in minimising blood wastage L. Bielby (Australia) |
| 17.00 - 17.30 | Is ONTraC on track? A fifteen year experience A. Howell (Canada) |
| 16.00 - 17.30 | Clinical II |
| 16.00 - 16.30 | Transfusion of neonates: evidence & complications A. Keir (Australia) |
| 16.30 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | WP Donors and donation |
| Complications of blood donation C. Napoli (Italy) | |
| Needle complications M. Townsend (USA) | |
| Apheresis complications H. Vrielink (Netherlands) |
| 08.30 - 09.30 | Jean Julliard Prize |
| 08.30 - 09.30 | Introductory presentation L. Fung (Australia) |
| 09.00 - 09.30 | Jean Julliard Prize Lecture: Transfusion-related acute lung injury (TRALI): Identification of novel risk factors and potential therapies R. Kapur (Sweden) |
| 09.30 - 10.00 | Coffee break |
| 10.00 - 11.30 | Presidential Award Session |
| 10.00 - 10.15 | Opening |
| 10.05 - 10.15 | Laudation H. Reesink (Netherlands) |
| 10.15 - 10.35 | Historical overview to prevent blood transmissible infectious agents H. Alter (USA) |
| 10.35 - 10.55 | Impact of hepatitis E virus infection on the safety of the blood supply H. Zaaijer (Netherlands) |
| 10.55 - 11.25 | Estimating risk and evaluating efficacy of risk reduction strategies M. Busch (USA) |
| 11.25 - 11.30 | Award Ceremony |
| 11.45 - 12.30 | ISBT General Assembly Members of ISBT only |
| 12.00 - 13.30 | Satellite Symposia |
| 12.00 - 14.00 | Lunch break |
| 14.00 - 15.30 | Donors & Donation |
| 14.00 - 14.30 | MSM and blood donation S. Sauleda (Spain) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Blood Products |
| 14.00 - 14.30 | All about frozen platelets M. Reade (Australia) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Blood Safety |
| 14.00 - 14.30 | Indian experience of introducing a haemovigilance scheme A. Bist (India) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Immunobiology |
| 14.00 - 14.30 | The role of molecular genotyping - a new era N. Gleadall (UK) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Blood and product supply |
| 14.00 - 14.30 | Towards a safe and sufficient blood supply in Africa D. Kyeyune (Uganda) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | Tranfusion Practitioners |
| 14.00 - 14.30 | ISBT Transfusion Practitioners survey feedback A. Dhesi (UK) |
| 14.30 - 15.30 | SELECTED ABSTRACTS |
| 14.00 - 15.30 | WP Blood supply management |
| Effective cold chain management R. Tocchetti (Australia) | |
| Outcome of survey on blood product wastage in developing countries M. Yazer (USA) | |
| Challenges to emergency transfusion in developing/resource constrained countries D. Kyeyune (Uganda) | |
| 15.30 - 16.00 | Coffee break |
| 16.00 - 17.30 | Donor safety |
| 16.00 - 16.30 | Donor health E. Di Angelantonio (UK) |
| 16.30 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Accreditation, Standards and Good Practice |
| 16.00 - 16.30 | The challenges of implementing the European good practice guidelines for blood components P. Mali (Lithuania) |
| 16.30 - 17.00 | The African Society for Blood Transfusion Step-Wise Accreditation Programme: organisation, achievements and challenges C. Tayou (Cameroon) |
| 17.00 - 17.30 | ISBT Developing Country Award Presentation: Initiatives for improving blood transfusional services in a regional public tertiary healthcare institution in India. N. Marwaha (India) |
| 16.00 - 17.30 | Adverse Reactions |
| 16.00 - 16.30 | ITP, from pathophysiology to treatment M. Michel (France) |
| 16.30 - 17.00 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | Clinical |
| 16.00 - 16.30 | Prevention & management of RBC Alloimmunisation in thalassemia A.A. Pourfathollah (Iran) |
| 16.30 - 17.30 | SELECTED ABSTRACTS |
| 16.00 - 17.30 | WP Rare donors/terminology/immunohematology |
| Introduction N. Thornton (UK) | |
| Name that specificity: investigating and identifying complex and exotic Rh variants T. Peyrard (France) | |
| Making it all happen for patients with rare blood V. Yahalom (Israel) | |
| Cataloging blood group variation with the help of new tools M.L. Olsson (Sweden) | |
| 16.00 - 17.30 | WP Cellular Therapy |
| The current status of human platelet lysate producation and manufacturing T. Burnouf (Taiwan) | |
| Platelet based clinical therapies: where are we now? C. Cohn (USA) | |
| Novel new platelet derived products: science, regulation and the evolving role of blood banks M. Koh (UK/Singapore) | |
| 17.45 - 18.45 | Poster session |
| 08.30 - 10.00 | Donors & Donation |
| 08.30 - 09.00 | An overview of donor base models in Sub-Sahara Africa: challenges and successes I. Bates (UK) |
| 09.00 - 09.30 | Building a blood system: the view froum Saudi Arabia M. Badawi (Saudi Arabia) |
| 09.30 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | Blood products |
| 08.30 - 09.00 | Automated blood component production J. Cid (Spain) |
| 09.00 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | Viruses |
| 08.30 - 09.00 | Splenic Macrophage Subsets and Their Functioning during Blood-Borne Infections R. D'Imperio Lima (Brazil) |
| 09.00 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | Immunobiology |
| 08.30 - 10.00 | SELECTED ABSTRACTS |
| 08.30 - 10.00 | Clinical |
| 08.30 - 09.00 | Lowering transfusion thresholds in haematopoetic stem cell transplantation A. Tinmouth (Canada) |
| 09.00 - 10.00 | SELECTED ABSTRACTS |
13.30 - 15.00 | WP Clinical - paediatric subgroup |
| 13.30 - 14.00 | Big Data applications in Pediatric Transfusion: size matters! TBA |
| 14.00 - 14.30 | Epidemiology: practice patterns and outcomes for children transfused for life threatening haemorrhage P. Spinella (USA) |
| 14.30 - 15.00 | Neonatal and paediatric haemovigilance H. New (UK) |
| 10.00 - 10.30 | Coffee break |
| 10.30 - 12.00 | Plenary Session: Platelets |
| 10.30 - 11.00 | In vitro production of platelets J. Thon (USA) |
| 11.00 - 11.30 | Novel roles for platelets in health and disease M. Rondina (USA) |
| 11.30 - 12.00 | Prevention of HLA alloimmune refractoriness K. Pavenski (Canada) |
| 12.00 - 13.30 | Satellite Symposia |
| 12.00 - 13.30 | Lunch break |
| 13.30 - 15.00 | Donor Recruitment |
| 13.30 - 14.00 | Strategies for Donor Recruitment in Ghana L. Asamoah Akuoko (Ghana) |
| 14.00 - 15.00 | SELECTED ABSTRACTS |
| 13.30 - 15.00 | Clinical Audit and Education |
| 13.30 - 14.00 | Improvind efficacy of audit and feedback to improve transfusion practice S. Stanworth (UK) |
| 14.00 - 15.00 | SELECTED ABSTRACTS |
| 13.30 - 15.00 | Products |
| 13.30 - 14.00 | The Effect of Sex and Age of the Donor on the Outcome of Transfusion Recipients G. Edgren (Sweden) |
| 14.00 - 14.30 | The Effect of Sex and Age of the Donor on the Outcome of Transfusion Recipients R. Middelburg (Netherlands) |
| 14.30 - 15.00 | SELECTED ABSTRACTS |
| 13.30 - 15.00 | Blood safety |
| 13.30 - 14.00 | Emerging infectious diseases C. Erikstrup (Denmark) |
| 14.00 - 15.00 | SELECTED ABSTRACTS |
| 13.30 - 15.00 | WP Platelet |
| 13.30 - 13.55 | New discoveries in immune mediated thrombocytopenia: implications for diagnosis and therapy H. Ni (Canada) |
| 13.55 - 14.20 | Platelet serology for allo and autoantibodies: pivotal or just nice to have? U. Sachs (Germany) |
| 14.20 - 14.35 | Report on the 19th International Platelet Immunology workshop L. Richard (Canada) |
| 14.35 - 15.00 | Generation of HPA-matched platelet precursors from humans iPS cells using CRISPR-mediated genome engineering P. Newman (USA) |
| 15.00 - 15.30 | Coffee Break |
| 15.30 - 17.30 | Plenary session - Transfusion Medicine past, present and future (Joint ISBT/AABB session) |
| 15.30 - 16.00 | Past D. Starr (USA) |
| 16.00 - 16.30 | Present S. Dzik (USA) |
| 16.30 - 17.00 | Future: Building a synthetic cell P. Schwille (Germany) |
| 17.00 - 17.30 | Surprise speaker |
| 17.00 - 17.15 | Closing ceremony |
| 20.00 - 23.00 | Congress Party / Banquet |
Tuesday June 5, 2018
7.00-8.15 hrs
Room 401, MTCC
The Young Investigators breakfast is a great opportunity for researchers, who are 40 years old or less to meet and talk to transfusion medicine experts, who will be available to discuss the challenges and joys of research and to give tips and suggestions.
The breakfast will take place in an informal setting in room 401, a room with a view in the Metro Convention Centre, Toronto.
Applying for this event is no longer possible as the closing date was May 3, 2018.
Please note that to attend this session, you need to have a good understanding of and be able to express yourself in English.
Monday June 4, 2018
7.00-8.15 hrs
Room 401, MTCC
The Transfusion Practitioner networking breakfast is a great opportunity for transfusion practitioners, and those interested in developing the role, to connect and discuss common interests and establish links that can be further developed throughout the congress and beyond.
The breakfast will take place in an informal setting in room 401, a room with a view in the Metro Convention Centre, Toronto.
Applying for this event is no longer possible as the closing date was May 11, 2018.
** Each parallel session will comprise (an) invited speaker(s) and selected abstracts for oral presentation.
JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE
“I think ISBT is the main forum for translating science and networking into best practices”
Become a member of ISBT
Join us now